Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with<sup>161</sup>Tb and<sup>177</sup>Lu: A Comparative Study-Reference-Cited by-同舟云学术

Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with¹⁶¹Tb and¹⁷⁷Lu: A Comparative Study

Published:2023-12-14 Issue: Volume: Page:jnumed.123.266233
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Holzleitner Nadine,Cwojdzinski Tatjana,Beck Roswitha,Urtz-Urban Nicole,Hillhouse Colin C.,Grundler Pascal V.,van der Meulen Nicholas P.,Talip Zeynep,Ramaekers Stijn,Van de Voorde Michiel,Ponsard Bernard,Casini Angela,Günther Thomas

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference9 articles.

1. The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy

2. Combination of terbium-161 with somatostatin receptor antagonists: a potential paradigm shift for the treatment of neuroendocrine neoplasms;Borgna;Eur J Nucl Med Mol Imaging.,2022

3. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients;Afshar-Oromieh;Eur J Nucl Med Mol Imaging.,2017

4. Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

5. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer;Kurth;Eur J Nucl Med Mol Imaging.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06